article thumbnail

Nitrosamine Mitigation: A Path to Regulatory Compliance

PharmaTech

In the wake of the Food and Drug Administration's (FDA's) latest guidance on nitrosamine contamination, ensuring compliance and safeguarding pharmaceutical products is more critical than ever.

article thumbnail

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

PFAS are synthetic chemicals, known as forever chemicals found in everyday products across the world, including pharmaceutical products. Crucially, planning ahead can help organisations avoid issues with compliance, while ensuring that the safety and sustainability of pharmaceutical products for patients remains a priority.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Product Life Cycle Management in Pharmaceuticals: The Case of Alendronate (Fosamax)

Cesare Ferrari

Alendronate must be taken in the morning on an empty stomach, with a full glass of water, and no other food or drinks for 30 minutes. This latest development exemplifies how innovation and customer centricity can sustain market relevance throughout a product’s lifecycle.

article thumbnail

The power of rapid methods for fungal ID

European Pharmaceutical Review

Fungal contamination in pharmaceutical products represents a potential hazard for two reasons. First, it may cause product spoilage; the metabolic versatility of fungi is such that any formulation ingredient may undergo chemical modification in the presence of a contaminating organism.

article thumbnail

What gene therapy manufacturers can gain from collaboration

European Pharmaceutical Review

Challenges in gene therapy manufacturing Photo: courtesy of PTC Therapeutics The biotech industry is facing a bottleneck in product manufacturing, with more than 1,000 gene therapies currently being developed as potential clinical candidates, 1 and not nearly enough capacity in manufacturing facilities to accommodate them.

article thumbnail

LAMP assays to enable rapid and sensitive detection of BCC

European Pharmaceutical Review

According to researchers, a ribB -based colorimetric loop-mediated isothermal amplification (LAMP) assay could become a fast and easy-to-perform detection method for testing non-sterile pharmaceuticals for BCC. Burkholderia species are one of the primary causes of non-sterile pharmaceutical product recalls and accounted for 45.3

article thumbnail

EMA publishes updated Q&A for ICH M10

European Pharmaceutical Review

The US Food and Drug Administration (FDA) implementation date was 7 November 2022. The post EMA publishes updated Q&A for ICH M10 appeared first on European Pharmaceutical Review. The draft ICH M10 guideline was published for comments in 2019.